Alastin Skincare, Inc. has received a third US Patent from the United States Patent and Trademark Office. The patent covers Alastin’s innovative science and products. US Patent No. 10,493,011 is entitled, "Peptide Compositions and Methods for Ameliorating Skin Laxity and Body Contour." This patent is directed to the composition and uses related to Alastin’s breakthrough TransFORM Body Treatment, when used alone as well as when used in conjunction with body-shaping procedures.
Alastin says this third formulation patent supports the brand's position as the fastest growing professionally dispensed skincare company in the US Aesthetic Market.
According to Dr. Laurie Casas, Clinical Professor of Surgery at the University of Chicago Medical Center and owner of Casas Aesthetic Plastic Surgery, "With TransFORM Body Treatment, I am finally able to provide patients with a topical product that perfectly complements invasive and non-invasive fat reduction and body contouring procedures and energy-based body sculpting procedures by accelerating results as well as improving skin tone and crepiness, ensuring patient's receive ideal post treatment outcomes." Dr. Jean Carruthers, Carruthers & Humphrey Cosmetic Dermatology, states, "I have had the opportunity to work directly with the scientists at Alastin to better understand their science while leading an innovative clinical study. Additionally, I have been personally using the Alastin products for over a year, and I am very impressed. TransFORM Body Treatment has significantly improved my overall skin texture as a stand-alone topical treatment."
"As we expand the Alastin portfolio, our patented TriHex Technology formulations continue to be the building blocks of our ongoing success," notes Diane S. Goostree, CEO of Alastin Skincare. "We are proud to be leading the U.S. aesthetic market and to enhancing the outcomes desired by our physician customers and their patients."
